ALNY logo

Alnylam Pharmaceuticals (ALNY) Cash and cash equivalents

annual cash & cash equivalents:

$966.43M+$153.74M(+18.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual cash & cash equivalents is $966.43 million, with the most recent change of +$153.74 million (+18.92%) on December 31, 2024.
  • During the last 3 years, ALNY annual cash & cash equivalents has risen by +$146.45 million (+17.86%).
  • ALNY annual cash & cash equivalents is now at all-time high.

Performance

ALNY Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

quarterly cash & cash equivalents:

$1.02B+$53.23M(+5.51%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly cash & cash equivalents is $1.02 billion, with the most recent change of +$53.23 million (+5.51%) on March 31, 2025.
  • Over the past year, ALNY quarterly cash & cash equivalents has increased by +$337.77 million (+49.54%).
  • ALNY quarterly cash & cash equivalents is now -10.26% below its all-time high of $1.14 billion, reached on June 30, 2019.

Performance

ALNY quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ALNY Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+18.9%+49.5%
3 y3 years+17.9%+90.9%
5 y5 years+76.6%+118.0%

ALNY Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+18.9%-7.3%+90.9%
5 y5-yearat high+94.6%-7.3%+168.7%
alltimeall timeat high+6144.3%-10.3%>+9999.0%

ALNY Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$1.02B(+5.5%)
Dec 2024
$966.43M(+18.9%)
$966.43M(-12.1%)
Sep 2024
-
$1.10B(+13.6%)
Jun 2024
-
$968.49M(+42.0%)
Mar 2024
-
$681.88M(-16.1%)
Dec 2023
$812.69M(-6.2%)
$812.69M(-21.3%)
Sep 2023
-
$1.03B(+57.0%)
Jun 2023
-
$657.80M(-2.1%)
Mar 2023
-
$672.25M(-22.4%)
Dec 2022
$866.39M(+5.7%)
$866.39M(-19.3%)
Sep 2022
-
$1.07B(+86.5%)
Jun 2022
-
$575.56M(+7.8%)
Mar 2022
-
$534.08M(-34.9%)
Dec 2021
$819.98M(+65.1%)
$819.98M(-25.0%)
Sep 2021
-
$1.09B(+46.7%)
Jun 2021
-
$745.77M(+96.5%)
Mar 2021
-
$379.54M(-23.6%)
Dec 2020
$496.58M(-9.2%)
$496.58M(-0.0%)
Sep 2020
-
$496.70M(-14.5%)
Jun 2020
-
$580.83M(+24.2%)
Mar 2020
-
$467.78M(-14.5%)
Dec 2019
$547.18M(+30.2%)
$547.18M(-40.7%)
Sep 2019
-
$923.30M(-18.7%)
Jun 2019
-
$1.14B(+56.7%)
Mar 2019
-
$724.96M(+72.5%)
Dec 2018
$420.15M(-34.9%)
$420.15M(+32.7%)
Sep 2018
-
$316.61M(-12.4%)
Jun 2018
-
$361.46M(-8.8%)
Mar 2018
-
$396.15M(-38.6%)
Dec 2017
$645.36M(+233.3%)
$645.36M(+219.4%)
Sep 2017
-
$202.04M(-50.6%)
Jun 2017
-
$408.67M(+138.9%)
Mar 2017
-
$171.08M(-11.6%)
Dec 2016
$193.62M(+7.0%)
$193.62M(+14.9%)
Sep 2016
-
$168.48M(-37.8%)
Jun 2016
-
$271.08M(+17.2%)
Mar 2016
-
$231.28M(+27.9%)
Dec 2015
$180.90M(+140.6%)
$180.90M(+21.2%)
Sep 2015
-
$149.22M(-1.4%)
Jun 2015
-
$151.26M(-50.7%)
Mar 2015
-
$306.58M(+307.8%)
Dec 2014
$75.18M
$75.18M(-9.1%)
Sep 2014
-
$82.72M(+2.5%)
DateAnnualQuarterly
Jun 2014
-
$80.73M(-77.0%)
Mar 2014
-
$350.59M(+559.4%)
Dec 2013
$53.17M(+3.4%)
$53.17M(+349.1%)
Sep 2013
-
$11.84M(-52.6%)
Jun 2013
-
$24.98M(-74.5%)
Mar 2013
-
$97.80M(+90.3%)
Dec 2012
$51.41M(-26.8%)
$51.41M(-32.2%)
Sep 2012
-
$75.84M(+57.1%)
Jun 2012
-
$48.27M(-21.8%)
Mar 2012
-
$61.74M(-12.1%)
Dec 2011
$70.23M(-5.9%)
$70.23M(-5.5%)
Sep 2011
-
$74.34M(+10.8%)
Jun 2011
-
$67.11M(-25.9%)
Mar 2011
-
$90.59M(+21.4%)
Dec 2010
$74.60M(-45.7%)
$74.60M(+59.1%)
Sep 2010
-
$46.88M(-29.2%)
Jun 2010
-
$66.18M(-42.4%)
Mar 2010
-
$114.95M(-16.4%)
Dec 2009
$137.47M(-28.3%)
$137.47M(+40.1%)
Sep 2009
-
$98.09M(-33.7%)
Jun 2009
-
$147.87M(-34.9%)
Mar 2009
-
$227.27M(+18.5%)
Dec 2008
$191.79M(+82.4%)
$191.79M(-2.5%)
Sep 2008
-
$196.74M(-20.5%)
Jun 2008
-
$247.54M(+26.1%)
Mar 2008
-
$196.28M(+86.7%)
Dec 2007
$105.16M(-17.8%)
$105.16M(-47.6%)
Sep 2007
-
$200.55M(+137.4%)
Jun 2007
-
$84.46M(+26.7%)
Mar 2007
-
$66.66M(-47.9%)
Dec 2006
$127.95M(+712.1%)
$127.95M(+260.3%)
Sep 2006
-
$35.52M(-0.4%)
Jun 2006
-
$35.65M(-37.2%)
Mar 2006
-
$56.80M(+260.5%)
Dec 2005
$15.76M(-22.3%)
$15.76M(+119.5%)
Sep 2005
-
$7.18M(-21.7%)
Jun 2005
-
$9.16M(-25.0%)
Mar 2005
-
$12.21M(-39.7%)
Dec 2004
$20.27M(-12.6%)
$20.27M(+39.4%)
Sep 2004
-
$14.54M(-54.4%)
Jun 2004
-
$31.89M(+47.6%)
Mar 2004
-
$21.61M(-6.8%)
Dec 2003
$23.19M(+49.9%)
$23.19M
Dec 2002
$15.48M
-

FAQ

  • What is Alnylam Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

What is Alnylam Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of ALNY is $966.43M

What is the all time high annual cash & cash equivalents for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual cash & cash equivalents is $966.43M

What is Alnylam Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, ALNY annual cash & cash equivalents has changed by +$153.74M (+18.92%)

What is Alnylam Pharmaceuticals quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of ALNY is $1.02B

What is the all time high quarterly cash & cash equivalents for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly cash & cash equivalents is $1.14B

What is Alnylam Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

Over the past year, ALNY quarterly cash & cash equivalents has changed by +$337.77M (+49.54%)
On this page